Cyclodextrin-based nanosponges as vehicles for antiviral drugs: challenges and perspectives

Nanomedicine (Lond). 2018 Mar;13(5):477-480. doi: 10.2217/nnm-2017-0383. Epub 2018 Jan 29.

Authors

David Lembo¹, Francesco Trotta², Roberta Cavalli³

Affiliations

¹ Department of Clinical & Biological Sciences, University of Turin, S. Luigi Gonzaga Hospital, Regione Gonzole, 10, 10043 Orbassano, Torino, Italy.
² Department of Chemistry, University of Turin, Via P. Giuria 7, 10125, Torino, Italy.
³ Department of Drug Science & Technology, University of Turin, Via P. Giuria 9, 10125, Torino, Italy.

PMID: 29376455
DOI: 10.2217/nnm-2017-0383

No abstract available

Keywords: antiviral drugs; nanosponges; viral infections; β-cyclodextrins.

Publication types

Editorial

MeSH terms

Antiviral Agents / administration & dosage
Antiviral Agents / chemistry*
Drug Carriers / chemistry*
Drug Liberation
Humans
Molecular Targeted Therapy
Nanoparticles / chemistry*
Solubility
Tissue Distribution
Virus Diseases / drug therapy*
beta-Cyclodextrins / chemistry*

Substances

Antiviral Agents
Drug Carriers
beta-Cyclodextrins